Reports

• Georgia Did Not Always Invoice Rebates to Manufacturers for Pharmacy and Physician-Administered Drugs

  

• Some Skin Substitute Manufacturers Did Not Comply with New ASP Reporting Requirements

  

• FY 2024 Congressional Budget Justification

  

• Medicare Improperly Paid Physicians for Epidural Steroid Injection Sessions

  

• Michigan MMIS and E&E Systems Security Controls Were Generally Effective, but Some Improvements Are Needed

  

• Florida Did Not Invoice Manufacturers for Some Rebates for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations

  

• State Agencies Did Not Always Ensure That Children Missing From Foster Care Were Reported to the National Center for Missing and Exploited Children in Accordance With Federal Requirements

  

• Medicare Part D Plan Sponsors and CMS Did Not Ensure That Transmucosal Immediate-Release Fentanyl Drugs Were Dispensed Only to Beneficiaries Who Had a Cancer Diagnosis

  

• Medicare Could Have Saved up to $216 Million Over 5 Years if Program Safeguards Had Prevented At-Risk Payments for Definitive Drug Testing Services

  

• Advisory Opinion 23-02

  

• Missouri Claimed Federal Medicaid Reimbursement for Tens of Millions in Consumer-Directed Personal Care Assistance Services That Did Not Comply With Federal and State Requirements

  

• Florida Made Capitation Payments for Enrollees Who Were Concurrently Enrolled in a Medicaid Managed Care Program in Another State

  

• Advisory Opinion 23-01

  

• Technical Assistance Brief: Implementation of Inflation-Indexed Rebates for Part B Drugs

  

• Early Challenges Highlight Areas for Improvement in COVID-19 Vaccination Programs

  

• Challenges With Vaccination Data Hinder State and Local Immunization Program Efforts To Combat COVID-19

  

• The National Institutes of Health and EcoHealth Alliance Did Not Effectively Monitor Awards and Subawards, Resulting in Missed Opportunities to Oversee Research and Other Deficiencies

  

• Greater Bergen Community Action, Inc., Did Not Manage Its Head Start Awards in Accordance With Federal and State Requirements

  

• Independent Attestation Review: National Institutes of Health Fiscal Year 2022 Detailed Accounting Submission and Budget Formulation Compliance Report for National Drug Control Activities, and Accompanying Required Assertions

  

• Independent Attestation Review: Centers for Disease Control and Prevention Fiscal Year 2022 Detailed Accounting Submission and Budget Formulation Compliance Report for National Drug Control Activities and Accompanying Required Assertions